Presentation References:
Contraception for Women and Couples with HIV
Note: Full-text versions of the references in bold can be found on the CD-ROM.
1
Joint United Nations Programme on HIV/AIDS (UNAIDS). 2006 Report on the Global AIDS
Epidemic. (Geneva and New York: UNAIDS, 2006a). [slide 3]
2
Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization (WHO). AIDS
Epidemic Update, December 2007. (Geneva: UNAIDS and WHO, 2007). [slide 4]
3
UNAIDS, 2006a. [slide 5]
4
Centro de Estudios Sociales y Demográficos (CESDEM); Secretaría de Estado de Salud Pública y
Asistencia Social (SESPAS); Comisión Ejecutiva para la Reforma del Sector Salud (CERSS); Consejo
Presidencial del SIDA (COPRESIDA); Agencia de los Estados Unidos para el Desarrollo Internacional
(USAID); Banco Mundial/CERSS; Banco Interamericano de Desarrollo/CERSS; Programa MEASURE
DHS+/ORC Macro. Encuesta Demográfica y de Salud (ENDESA) 2002. Calverton, MD: CESDEM
and ORC Macro, 2003. [slide 6]
5
Institut National de la Statistique (INS), ORC Macro. Enquête Démographique et de Santé du
Cameroun 2004. Calverton, MD: INS and ORC Macro, 2004. [slide 6]
6
Central Bureau of Statistics (CBS) [Kenya], Ministry of Health (MOH) [Kenya], ORC Macro. Kenya
Demographic and Health Survey 2003. Calverton, MD: CBS, MOH, and ORC Macro, 2004. [slide 6]
7
Central Statistical Office [Zambia], Central Board of Health [Zambia], ORC Macro. Zambia
Demographic and Health Survey 2001-2002. Calverton, MD: Central Statistical Office, Central Board
of Health, and ORC Macro, 2003. [slide 6]
8
CBS, MOH, and ORC Macro, July 2004. [slide 7]
9
Joint United Nations Programme on HIV/AIDS (UNAIDS)/Inter-Agency Task Team on Gender and
HIV/AIDS. Fact Sheet #8: HIV/AIDS, Gender and the Prevention of Mother-to-Child Transmission
(PMTCT). Resource Pack on Gender HIV/AIDS. New York: UNAIDS, 2006b. [slide 8]
10 UNAIDS, 2006a. [slide 8]
11 UNAIDS and WHO, 2007. [slide 9]
12 United Nations Children’s Fund (UNICEF). The State of the World’s Children 2007: Women and
Children The Double Dividend of Gender Equality. (New York: UNICEF, 2006)117. [slide 10]
13 United Nations Children’s Fund (UNICEF). Africa’s Orphaned and Vulnerable Generations: Children
Affected by AIDS. New York: UNICEF, 2006. [slide 10]
14 Gregson S, Nyamukapa C, Garnett G, et al. HIV infection and reproductive health in teenage women
orphaned and made vulnerable by AIDS in Zimbabwe, AIDS Care 2005;17(7):785-94. [slide 10]
15 Birdthistle I, Glynn JR, Floyd S, et al. From affected to infected? Understanding the sexual health
risks to adolescent girls affected by AIDS in urban Zimbabwe. Poster presentation at Zimbabwe AIDS
conference, September 2004. [slide 10]
16 The Global Coalition on Women and AIDS (UNAIDS). Keeping the Promise: An Agenda for Action
on Women and AIDS. New York: UNAIDS, 2006. [slide 11]
August 2008
Contraception for Women and Couples with HIV
References 1
17 Moss GB, Clemetson D, D’Costa L, et al. Association of cervical ectopy with heterosexual
transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J
Infect Dis 1991;164(3):588-91. [slide 11]
18 World Health Organization (WHO). Strategic Approaches to the Prevention of HIV Infection in
Infants: Report of a WHO Meeting. Presentation at Morges, Switzerland, March 20–22, 2002.
[slide 13]
19 U.S. Agency for International Development (USAID), Bureau for Global Health. Adding Family
Planning to PMTCT Sites Increases the Benefits of PMTCT. Washington, DC: USAID, 2003.
[slide 14]
20 Population Reference Bureau. Datafinder. Indicator: Contraceptive Use Among Married Women,
Modern Methods. Available: www.prb.org. [slide 16]
21 Population Reference Bureau. Datafinder. Indicator: Unmet Need for Family Planning.
Available: www.prb.org. [slide 16]
22 Ross JA, Winfrey WL. Unmet need for contraception in the developing world and the former Soviet
Union: an updated estimate. Int Fam Plann Perspect 2002;28(3):138-43. [slide 17]
23 Saada M, Le Chenadec J, Berrebi A, et al. Pregnancy and progression to AIDS: results of the French
prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS 2000;14(15):2355-60. [slide 19]
24 Tai JH, Udoji MA, Barkanic, G, et al. Pregnancy and HIV disease progression during the era of highly
active antiretroviral therapy. J Infect Dis 2007;196(7):1044-52. [slide 19]
25 Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a
systematic review of the literature and meta-analysis. BJOG 1998;105(8):836-48. [slide 19]
26 Preble EA, Huber D, Piwoz EG. Family Planning and the Prevention of Mother-to-Child Transmission
of HIV: Technical and Programmatic Issues. Arlington, VA: Advance Africa, 2003. [slide 20]
27 Chen JL, Philips KA, Kanouse DE, et al. Fertility desires and intentions of HIV-positive men and
women. Fam Plann Perspect 2001;33(4):144-52. [slide 22]
28 King R, Estey J, Allen S, et al. A family planning intervention to reduce vertical transmission of HIV
in Rwanda. AIDS 1995;9(Suppl. 1):S45-S51. [slide 23]
29 World Health Organization (WHO). Antiretroviral Therapy for HIV Infection in Adults and
Adolescents: Recommendations for a Public Health Approach – 2006 Revised. Geneva: WHO, 2006.
[slide 27]
30 Dabis F, Leroy V, Castetbon K, et al. Preventing mother-to-child transmission of HIV-1 in Africa in
the year 2000. AIDS 2000;14(8):1017-26. [slide 28]
31 U.S. Centers for Disease Control and Prevention (CDC). Updated U.S. public health service guidelines
for the management of occupational exposures to HIV and recommendations for postexposure
prophylaxis. MMWR 2005;54(RR9). [slide 28]
32 Shelton JD, Peterson EA. The imperative for family planning in ART therapy in Africa. Lancet
2004;364(9449):1916-18. [slide 29]
33 Powderly WG. Long-term exposure to lifelong therapies. J Acquir Immune Defic Syndr 2002;29(Suppl
1):S28-S40. [slide 29]
August 2008
Contraception for Women and Couples with HIV
References 2
34 World Health Organization (WHO). Scaling Up Antiretroviral Therapy in Resource-Limited Settings:
Treatment Guidelines for a Public Health Approach, 2003 Revision. Geneva, Switzerland: WHO,
2004a. [slide 29]
35 Cates W. Use of contraception by HIV-infected women. IPPF Med Bull 2001:35(1):1-2. [slide 31]
36 Pariani S, Heer DM, Van Arsdol MD Jr. Does choice make a difference to contraceptive use?
Evidence from East Java. Stud Fam Plann 1991;22(6):384-90. [slide 32]
37 Huezo C, Malhotra U. Choice and Use-Continuation of Methods of Contraception: A Multicentre
Study. London, UK: International Planned Parenthood Federation, 1993. [slide 32]
38 WHO. Medical Eligibility Criteria for Contraceptive Use, Third Edition. Geneva, Switzerland: WHO,
2004b; updated 2008. [slide 41]
39 WHO, 2004b; updated 2008. [slide 42]
40 WHO, 2004b; updated 2008. [slide 43]
41 WHO, 2004b; updated 2008. [slide 44]
42 World Health Organization/Department of Reproductive Health and Research (WHO), Johns Hopkins
Bloomberg School of Public Health/Center for Communication Programs/INFO Project (CCP). Family
Planning: A Global Handbook for Providers. Baltimore, MD and Geneva: CCP and WHO, 2007.
[slide 46]
43 Hatcher RA, Trussell J, Nelson AL, et al. Contraceptive Technology. Nineteenth Revised Edition. New
York: Ardent Media, Inc., 2007. [slide 47]
44 Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane
Database Syst Rev 2002;(1):CD003255. [slide 48]
45 Deschamps M-M, Pape JW, Hafner A, et al. Heterosexual transmission of HIV in Haiti. Ann Inter Med
1996;125:324-30. [slide 48]
46 Hatcher, 2007. [slide 48]
47 WHO, 2004b; updated 2008. [slide 49]
48 Diaz T, Schable B, Chu SY. Relationship between use of condoms and other forms of contraception
among human immunodeficiency virus-infected women. Obstet Gynecol 1995;86(2):277-82. [slide 51]
49 Leitz G, Mildvan D, McDonough M, et al. Nevirapine (VIRAMUNE, NCP) and ethinyl
estradiol/norethindrone (ORTHO-NOVUM 1/35 [21 pack] EE/NET) interaction study in HIV-1
infected women. 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA,
January 30-February 2, 2000. [slide 55]
50 Piscitelli S, Flexner C, Minor J, et al. Drug interactions in patients infected with human
immunodeficiency virus. Clin Infect Dis 1996;23(4):685-93. [slide 55]
51 WHO, 2004b. [slide 57]
52 Ouellet D, Hsu A, Qian J, et al. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in
healthy female volunteers. Br J Clin Pharmacol 1998;46(2):111-116. [slide 57]
August 2008
Contraception for Women and Couples with HIV
References 3
53 University of Liverpool. Drug Interaction Charts. Available: www.hiv-druginteractions.org. Maintained
by the University of Liverpool and eMED-MEDIA, last updated August 27, 2008. [slide 57]
54 WHO, 2004b. [slide 58]
55 Cohn SE, Watts D, Lertora J, et al. An open-label, non-randomised study of the effect of depomedroxyprogesterone acetate on the pharmacokinetics of selected protease inhibitors and nonnucleoside reverse transcriptase inhibitors therapies among HIV-infected women. 12th Conference on
Retroviruses and Opportunistic Infections, Boston, February 2005, abstract 82. [slide 58]
56 Lavreys L, Chohan V, Overbaugh J, et al, Hormonal contraception and risk of cervical infections
among HIV-1 seropositive Kenyan women. AIDS 2004;18(16):2179-84. [slide 60]
57 Wang CC, Kreiss JK, Reilly M. Risk of HIV infection in oral contraceptive pill users: a meta-analysis.
J Acquir Immune Defic Syndr 1999;21(1):51-58. [slide 61]
58 Wang CC, McClelland RS, Overbaugh J, et al. The effect of hormonal contraception on genital tract
shedding of HIV-1. AIDS 2004;18(2):205-9. [slide 61]
59 John GC, Nduati RW, Mbori-Ngacha DA, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load,
genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001;183(2):206-12. [slide 61]
60 McClelland RS, Wang CC, Mandaliya K, et al. Treatment of cervicitis is associated with decreased
cervical shedding of HIV-1. AIDS 2001;15(1):105-10. [slide 62]
61 Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding,
sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d’Ivoire.
AIDS 1997;(12):F85-93. [slide 62]
62 Lavreys L, Baeten JM, Kreiss JK, et al. Injectable contraceptive use and genital ulcer disease during
the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis 2004;189(2):30311. [slide 63]
63 Sagar M, Lavreys L, Baeten J, et al. Infection with multiple human immunodeficiency virus type 1
variants is associated with faster disease progression. J Virol 2003;77(23):12921-26. [slide 63]
64 WHO, 2004b; updated 2008. [slide 64]
65 Hatcher, 2007. [slide 65]
66 WHO, 2004b; updated 2008. [slide 65]
67 WHO, 2004b, updated 2008. [slide 66]
68 Mildvan, 2002. [slide 66]
69 Said S, Omar K, Koetsawang S, et al. A multicentred phase III comparative clinical trial of depotmedroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive
efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for
Fertility Regulation. Special Programme of Research, Development and Research Training in Human
Reproduction. Contraception 1986;34(3):223-35. [slide 66]
70 WHO, 2004b; updated 2008. [slide 67]
71 Mildvan, 2002. [slide 67]
August 2008
Contraception for Women and Couples with HIV
References 4
72 Hatcher, 2007. [slide 69]
73 Morrison CS, Sekadde-Kigondu C, Sinei SK, et al. Is the intrauterine device appropriate contraception
for HIV-1-infected women? BJOG 2001;108(8):784-90. [slide 70]
74 Richardson BA, Morrison CS, Sekadde-Kigondu C, et al. Effect of intrauterine device on cervical
shedding of HIV-1 DNA. AIDS 1999;13(15):2091-97. [slide 71]
75 WHO, 2004b; updated 2008. [slide 72]
76 Hatcher, 2007. [slide 73]
77 Wilkinson D, Ramjee G, Tholandi M, et al. Nonoxynol-9 for preventing vaginal acquisition of HIV
infection by women from men (Cochrane Review). Cochrane Database Syst Rev 2002;(4):CD003936.
[slide 73]
78 Wilkinson D, Ramjee G, Tholandi M, et al. Nonoxynol-9 for preventing vaginal acquisition of sexually
transmitted infections by women from men (Cochrane Review). Cochrane Database Syst Rev
2002;(4):CD003939. [slide 73]
79 WHO, Contraceptive Research and Development Project (CONRAD). Safety of Nonoxynol-9 When
Used for Contraception: Report from WHO/CONRAD Technical Consultation, October 2001. Geneva,
Switzerland: WHO and CONRAD, 2002. [slide 73]
80 Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on
HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002;360(9338):97177. [slide 73]
81 Hatcher, 2007. [slide 74]
82 Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: the unexplored
promise of internal vaginal barrier devices. AIDS 2001;15(13):1595-1602. [slide 74]
83 Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal
mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000;74(13):
6087-95. [slide 74]
84 Padian N, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV
acquisition in southern African women: a randomised controlled trial. Lancet 2007;370(9583):251-61.
[slide 74]
85 WHO, 2004b; updated 2008. [slide 75]
86 Gottlieb G, Nickle D, Jensen M, et al. HIV-1 superinfection in a rapid disease progressor: rapid
replacement of the initial strain with the superinfecting virus by natural selection. Eleventh Conference
on Retroviruses and Opportunistic Infections, San Francisco, CA, February 8-11, 2004. [slide 75]
87 Hatcher, 2007. [slide 76]
88 WHO, 2004b; updated 2008. [slide 77]
89 Hatcher, 2007. [slide 78]
90 Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission
of HIV-1: a randomized clinical trial. JAMA 2000;283(9):1167-74. [slide 79]
August 2008
Contraception for Women and Couples with HIV
References 5
91 De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in
resource-poor countries: translating research into policy and practice. JAMA 2000;283(9):1175-82.
[slide 79]
92 World Health Organization (WHO). Consensus Statement – WHO HIV and Infant Feeding Technical
Consultation. Held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV Infections
in Pregnant Women, Mothers and their Infants, October 25-27, 2006. Geneva: WHO, 2006. [slide 79]
93 CCP and WHO, 2007. [slide 80]
94 WHO, 2004b; updated 2008. [slide 81]
95 Chervenak FA, McCullough LB. Common ethical dilemmas encountered in the management of HIVinfected women and newborns. Clin Obstet Gynecol 1996;39(2):411-19. [slide 85]
96 McIntyre J. HIV in Pregnancy: A Review (Geneva, Switzerland: World Health Organization/UNAIDS,
1999)7. [slide 86]
97 Bessinger R, Clark R, Kissinger P, et al. Pregnancy is not associated with the progression of HIV disease
in women attending an HIV outpatient program. Am J Epidemiol 1998;147(5):434-40. [slide 86]
98 Immunological markers in HIV-infected pregnant women. The European Collaborative Study and the
Swiss HIV Pregnancy Cohort. AIDS 1997;11(15):1859-65. [slide 86]
99 Vimercati A, Greco P, Lopalco PL, et al. Immunological markers in HIV-infected pregnant and nonpregnant women. Eur J Obstet Gynecol Reprod Biol 2000;90(1):37-41. [slide 86]
100 Gray R, Li X, Serwadda D, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a
prospective study. Lancet 2005;366(9492):1182-88. [slide 86]
101 Working Group on Mother-to-Infant Transmission of HIV. Rates of mother-to-infant transmission of
HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr
Hum Retrovirol 1995;8(5):506-10. [slide 86]
102 Dabis F, Leroy V, Castetbon K, et al. Preventing mother-to-child transmission of HIV-1 in Africa in
the year 2000. AIDS 2000;14(8):1017-26. [slide 86]
103 ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human
immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med
Hyg 2004;71(2 Suppl):41-54. [slide 87]
104 WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality.
Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed
countries: a pooled analysis. Lancet 2000;355(9202):451-55. [slide 87]
August 2008
Contraception for Women and Couples with HIV
References 6